Welcome to the 2nd Novel Ingredients for Infant Formula & Nutrition Summit

The global infant formula market is diversifying and innovating, and so is the 2nd Novel Ingredients for Infant Formula & Nutrition Summit. This critical forum, formerly the Bioactive Infant Formula & Nutrition Summit, returned with a deeper focus on the science that underpins world-class pre-clinical and clinical development of novel bioactive ingredients and nutrients, including HMOs, MFGMs, lactoferrin, alpha-Lactalbumin, and more. Critically, it explores how this can and is supporting global regulatory success.

Uniquely positioned as an industry-led forum, the 2025 conference was backed by titans like Abbott Nutrition, Reckitt/Mead Johnson Nutrition, and Arla Food Ingredients, as well as emerging innovators such as Bobbie, ByHeart, Kabrita, and Checkerspot. It offered a case study playbook, supporting your progression toward superior formulas. Our audience learned strategies to engage with regulators, devise successful preclinical development approaches, benchmark clinical trial design strategies, and explored next-generation ingredients to close gaps in the nutritional, health, and immunological benefits of infant formulas.

The 2025 conference provided focused networking with 90+ clinical development, nutrition, regulatory, and innovation leaders from infant formula manufacturers and ingredient providers, alongside academic leaders, and key service providers like CROs spearheading human milk research efforts. It aimed to leave its attendees with a scientific and regulatory roadmap to consolidate or widen their market share and join forces with fellow industry leaders in a united effort to transform the future of infant formula.